CODX Positive Sentiment
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
Friday, October 31, 2025 BiopharmaWatch Research 1 min read Key Takeaway: Co-Diagnostics, Inc. has announced the release date for its third quarter 2025 earnings, scheduled for November 13, 2025, after market close. The company will also host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the financial results. Key management will participate in the call, enhancing communication with investors.
Full Press Release Details
SALT LAKE CITY,Oct. 31, 2025/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ:CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2025 financial results on Thursday, November 13, 2025, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
The conference call and webcast will be available via:
Webcast:ir.co-dx.comon theEvents & Webcastspage, or accessible directlyhere
Conference Call: 1-888-880-3330 (Toll Free) or 1-646-357-8766 (Toll)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.Co-Diagnostics, Inc. (Nasdaq:CODX), a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.